Page last updated: 2024-09-02

caffeic acid phenethyl ester and 3,4-di-o-caffeoylquinic acid

caffeic acid phenethyl ester has been researched along with 3,4-di-o-caffeoylquinic acid in 1 studies

Compound Research Comparison

Studies
(caffeic acid phenethyl ester)
Trials
(caffeic acid phenethyl ester)
Recent Studies (post-2010)
(caffeic acid phenethyl ester)
Studies
(3,4-di-o-caffeoylquinic acid)
Trials
(3,4-di-o-caffeoylquinic acid)
Recent Studies (post-2010) (3,4-di-o-caffeoylquinic acid)
840146951140

Protein Interaction Comparison

ProteinTaxonomycaffeic acid phenethyl ester (IC50)3,4-di-o-caffeoylquinic acid (IC50)
Aldo-keto reductase family 1 member B10Homo sapiens (human)0.24
Amyloid-beta precursor proteinHomo sapiens (human)4.7
Aldo-keto reductase family 1 member B1Homo sapiens (human)0.078

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
El-Kabbani, O; Endo, S; Hara, A; Hu, D; Ifuku, S; Li, J; Matsunaga, T; Ohta, S; Soda, M; Takemura, M; Toyooka, N; Wada, R; Yamamura, K; Zhao, HT1

Other Studies

1 other study(ies) available for caffeic acid phenethyl ester and 3,4-di-o-caffeoylquinic acid

ArticleYear
Design, synthesis and evaluation of caffeic acid phenethyl ester-based inhibitors targeting a selectivity pocket in the active site of human aldo-keto reductase 1B10.
    European journal of medicinal chemistry, 2012, Volume: 48

    Topics: Aldehyde Reductase; Aldo-Keto Reductases; Antineoplastic Agents; Caffeic Acids; Catalytic Domain; Cell Survival; Enzyme Inhibitors; HeLa Cells; Humans; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Mass Spectrometry; Models, Molecular; Molecular Dynamics Simulation; Mutagenesis, Site-Directed; Propolis; Spectrophotometry, Infrared; Structure-Activity Relationship; U937 Cells

2012